The page is the record's research on the issuer — no analyst, no rating, no view. # Chordia Therapeutics Inc. (Growth Market: 190A) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing The issuer is Chordia Therapeutics Inc., listed on the Growth Market, with ticker 190A. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted. ## The disclosure read The record holds 8 filings across 5 filing days in the twelve months to 2026-11-06. The filings comprise 2 ad hoc, 1 prospectus, 3 regulatory filings and 2 results. The median gap between filing days is 69.5 days. The latest filing is dated 2026-08-24 and is a prospectus, 74 days before the record date. On the Growth Market the median cadence gap is 42 days across 598 issuers, the median filing count is 8.0, and the median latency is 85.0 days. On 3250 Pharmaceutical the median cadence gap is 49.5 days across 80 issuers, the median filing count is 8.0, and the median latency is 85.0 days. ## Auditor The auditor of record is 有限責任 あずさ監査法人. The location of the auditor is not on the record. The auditor changes are not on the record, as the market's record does not carry a lifecycle type map for this register. ## Events and halts The listing, delisting, name change, domicile change and segment move lines are not on the record, as the index does not carry a lifecycle type for this market. The issuer is listed and not halted. ## Orderability For the client category Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the issuer's class carries no CFI to place on the scope bridge, and no scope object names the class, so the issuer is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page as read. The count is 0. ## Open research One openly published research note is on the record, published by FISCO Ltd. on 2025-12-12. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/190A (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100X63V (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.chordiatherapeutics.com/en/ir/library/report/main/011115/teaserItems1/04/linkList/0/link/20251212_report.pdf (open research) - https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/190A (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-GROWTH/190A · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp